SOPHARMA AD: Current report 29 buy back 12032015

opublikowano: 2015-03-12 13:42

Spis treści:

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załącznikĂłw:
Current_report_29_buy_back_12032015.doc (REPORT)

	POLISH FINANCIAL SUPERVISION AUTHORITY
				UNI - EN REPORT No		29	/	2015
	Date of issue:		2015-03-12
	Short name of the issuer
	SOPHARMA AD
	Subject
	Current report 29 buy back 12032015
	Official market - legal basis
	Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
	Unofficial market - legal basis
	Contents of the report:
	SOPHARMA AD hereby informs that from 5 March 2015 up to and including 11 March 2015 the Company bought 900 own shares representing 0.00067% of the share capital of the Company, at a total value of 2 970.00 BGN on the Bulgarian Stock Exchange, the average price per share was 3.30 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 5 147 956, representing 3.82% of the share capital of the Company.
	Annexes
	File				Description
	Current report 29 buy back 12032015.docCurrent report 29 buy back 12032015.doc				Current report 29 buy back 12032015

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

16

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

nd

(NIP)

(REGON)

	SIGNATURE OF PERSONS REPRESENTING THE COMPANY
	Date	Name	Position / Function	Signature
	2015-03-12	Ognian Donev	Executive director